Novo CEO pressed by Senate to cut costs of weight problems, diabetes prescription drugs CEO Lars Fruergaard Jørgensen instructed lawmakers the business would contemplate new talks with insurers in regards to the record rates of Wegovy and copyright when they pledge to help keep the medicines on their own formularies. https://arizonahardteanutritionfa27261.widblog.com/85620083/considerations-to-know-about-healthcare-news